MYDA Advisors’s Fortress Value Acquisition Corp. III Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share FVT.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-19,500
Closed -$16K 348
2021
Q3
$16K Buy
+19,500
New +$21.3K ﹤0.01% 258

Other funds holding FVT.WS

MYDA Advisors's FVT.WS Position: Q4 2021 in Review

MYDA Advisors sold out of Fortress Value Acquisition Corp. III Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share (FVT.WS) in Q4 2021, closing a stake of 19,500 shares — an estimated $16K sold.

MYDA Advisors first reported a position in FVT.WS in Q3 2021 and held it in 1 quarter. The position peaked at $16K in Q3 2021. 43 funds tracked by Wall St. Rank hold FVT.WS as of Q4 2021.

  • MYDA Advisors reported no remaining Fortress Value Acquisition Corp. III Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position as of Q4 2021 after selling out during the quarter.
  • MYDA Advisors sold 19,500 Fortress Value Acquisition Corp. III Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share shares in Q4 2021, an estimated $16K.
  • MYDA Advisors first reported a position in Fortress Value Acquisition Corp. III Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share in Q3 2021 and held it in 1 quarter.
  • MYDA Advisors's Fortress Value Acquisition Corp. III Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position peaked at $16K in Q3 2021.
  • 43 funds tracked by Wall St. Rank held Fortress Value Acquisition Corp. III Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share as of Q4 2021.

Based on MYDA Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.